progression-free survival

You have access
Correlation Between CA125 Levels After Sixth Cycle of Chemotherapy and Clinical Outcome in Advanced Ovarian Carcinoma
ANGIOLO GADDUCCI, ALICE MENICHETTI, ILARIA GUIGGI, MARGHERITA NOTARNICOLA and STEFANIA COSIO

Anticancer Research February 2015, 35 (2) 1099-1104;
You have access
Clinicopathological Factors Affecting Progression-Free Survival of Patients With Previously Treated Advanced Non-Small Cell Lung Cancer After S-1 Therapy With or Without Bevacizumab
KATSUHIRO MASAGO, SHIRO FUJITA, AKITO HATA, REIKO KAJI, KYOKO OHTSUKA, CHIYUKI OKUDA, JUMPEI TAKESHITA and NOBUYUKI KATAKAMI

Anticancer Research December 2014, 34 (12) 7467-7472;
You have access
Sequential Tyrosine Kinase Inhibitors (TKIs) in Metastatic Renal Cell Carcinoma: Results from a Large Cohort of Patients
PAMELA BIONDANI, ELENA VERZONI, VALTER TORRI, LUCA PORCU, PAOLO GRASSI, ISABELLA TESTA, FILIPPO DE BRAUD and GIUSEPPE PROCOPIO

Anticancer Research May 2014, 34 (5) 2395-2398;
You have access
Platinum-based Doublet Chemotherapy plus Bevacizumab Without Bevacizumab Maintenance in Advanced Non-small Cell Lung Cancer (NSCLC)
DORTE SCHOU NØRØXE, SANDRA WALLEREK and JENS BENN SØRENSEN

Anticancer Research August 2013, 33 (8) 3275-3278;

Main menu